Serum lipoproteins and C567-INH activity.
D000818:Animals; D003182:Complement C5 / Q000037:antagonists & inhibitors*; D003183:Complement C6 / Q000037:antagonists & inhibitors*; D003184:Complement C7 / Q000037:antagonists & inhibitors*; D003185:Complement C8 / Q000037:antagonists & inhibitors; D003186:Complement C9 / Q000037:antagonists & inhibitors; D003169:Complement Inactivator Proteins; D006168:Guinea Pigs; D006461:Hemolysis; D006801:Humans; D008074:Lipoproteins / Q000097:blood* / Q000494:pharmacology; D011107:Polylysine / Q000494:pharmacology; D012995:Solubility
D003182:Complement C5; D003183:Complement C6; D003184:Complement C7; D003185:Complement C8; D003186:Complement C9; D003169:Complement Inactivator Proteins; D008074:Lipoproteins; D011107:Polylysine